On Tuesday, Mind Medicine Inc (NASDAQ: MNMD) opened lower -9.94% from the last session, before settling in for the closing price of $5.43. Price fluctuations for MNMD have ranged from $4.83 to $11.36 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 36.90% at the time writing. With a float of $74.09 million, this company’s outstanding shares have now reached $75.37 million.
The extent of productivity of a business whose workforce counts for 74 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mind Medicine Inc (MNMD) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mind Medicine Inc is 1.20%, while institutional ownership is 49.60%. The most recent insider transaction that took place on Mar 25 ’25, was worth 142,942. In this transaction Chief Executive Officer of this company sold 21,208 shares at a rate of $6.74, taking the stock ownership to the 856,556 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Chief Medical Officer sold 6,836 for $6.74, making the entire transaction worth $46,075. This insider now owns 446,177 shares in total.
Mind Medicine Inc (MNMD) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.90% per share during the next fiscal year.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Check out the current performance indicators for Mind Medicine Inc (MNMD). In the past quarter, the stock posted a quick ratio of 7.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.54, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.77 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
The latest stats from [Mind Medicine Inc, MNMD] show that its last 5-days average volume of 1.85 million was inferior to 1.98 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 20.37%. Additionally, its Average True Range was 0.55.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 2.12%, which indicates a significant decrease from 5.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.57% in the past 14 days, which was lower than the 86.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.99, while its 200-day Moving Average is $6.96. Now, the first resistance to watch is $5.50. This is followed by the second major resistance level at $6.12. The third major resistance level sits at $6.48. If the price goes on to break the first support level at $4.52, it is likely to go to the next support level at $4.16. The third support level lies at $3.54 if the price breaches the second support level.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
There are currently 75,368K shares outstanding in the company with a market cap of 368.55 million. Presently, the company’s annual sales total 0 K according to its annual income of -108,680 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -34,740 K.
